Public Profile

Gador S.A.

Gador S.A., a prominent player in the pharmaceutical industry, is headquartered in Argentina (AR) and has established a significant presence across Latin America. Founded in 1945, the company has consistently evolved, marking key milestones in the development of innovative healthcare solutions. Specialising in the production of high-quality generic and branded medications, Gador S.A. is renowned for its commitment to research and development, ensuring that its products meet rigorous international standards. The company’s diverse portfolio includes pharmaceuticals across various therapeutic areas, making it a trusted name among healthcare professionals. With a strong market position, Gador S.A. has achieved notable recognition for its contributions to public health, reinforcing its reputation as a leader in the pharmaceutical sector. Its dedication to quality and innovation continues to drive its success in the competitive landscape of healthcare.

DitchCarbon Score

How does Gador S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Gador S.A.'s score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Gador S.A.'s reported carbon emissions

Gador S.A., headquartered in Argentina, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions statistics, it is important to note that Gador S.A. has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi) or similar climate pledges. This lack of publicly available information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability and carbon neutrality, Gador S.A. may benefit from establishing clear climate commitments and reduction initiatives to align with global standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Gador S.A.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Gador S.A. is in AR, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Gador S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Abbott

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Knight Therapeutics Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

PROCAPS

CO
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Laboratorios Bago De Bolivia S.A.

BO
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Hypera Pharma

BR
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Pint Pharma GmbH

AT
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers